Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04548622 · ClinicalTrials.gov registry record · NA
Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT04548622 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 15 participants.
The verdict
NCT04548622, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The primary purpose of this study was to conduct fMRI neuroimaging studies prior to and subsequent to the rTMS intervention. The intent was to ascertain changes in regional brain activation and connectivity that most robustly predict level of improvement in auditory hallucinations elicited by bilateral rTMS as assessed by the primary outcome variables.
Interventions
- DEVICE Magstim Rapid 2 system triggering Magstim Super Rapid system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04548622
The ClinicalTrials.gov registry entry for NCT04548622 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Magstim Rapid 2 system triggering Magstim Super Rapid system is the first listed.
NCT04548622 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04548622 about?
NCT04548622 is a clinical study titled "Bilateral Repetitive Transcranial Magnetic Stimulation for Auditory Hallucinations Results". The primary purpose of this study was to conduct fMRI neuroimaging studies prior to and subsequent to the rTMS intervention. The intent was to ascertain changes in regional brain activation and connectivity that most robustly predict level of improvement in auditory hallucinations elicited by bilate...
What is the current status of trial NCT04548622?
This trial is currently terminated. It is a NA study. The enrollment target is 15 participants. The study started on 2012-09. Estimated completion is 2016-10.
What interventions are being tested in trial NCT04548622?
The interventions under investigation include: Magstim Rapid 2 system triggering Magstim Super Rapid system (DEVICE).
Who is sponsoring clinical trial NCT04548622?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.